Company Intelligence

HypaHub

HypaHub is a Cloud-Based Bioinformatics and AI Platform. It is the first HIPAA-compliant Bioinformatics SaaS that runs natively on users' clouds, providing both operation- and price-transparency. Our product is a one-stop shop to access complex technologies…

In this profile

Quick Facts

  • Founded 2022
  • Headquarters San Francisco, United States
  • Country United States
  • Industry AI in Enterprise Software
  • Company Type Early
  • Status Acquired
  • Website Official site
  • Last Reviewed Aug 2026

Executive Summary

HypaHub is a Cloud-Based Bioinformatics and AI Platform. It is the first HIPAA-compliant Bioinformatics SaaS that runs natively on users' clouds, providing both operation- and price-transparency.

Our product is a one-stop shop to access complex technologies designed for scientists building data applications or performing data analytics to extract insights. It automates the creation and manages the operation of computing resources, eliminating the need for enterprises to set up and maintain a high-end R&D cloud infrastructure.

Why It Matters

A Cloud-Based Bioinformatics and AI Platform

Recent Developments

  1. Company status

    Documented status on Brel profile: Acquired.

    Source
  2. 2022 Company founded

    HypaHub was founded in 2022 per the company profile source on file.

    Source

Connected Reports

Connected Insights

Industries

HypaHub is a Cloud-Based Bioinformatics and AI Platform. It is the first HIPAA-compliant Bioinformatics SaaS that runs natively on users’ clouds, providing both operation- and price-transparency.

Our product is a one-stop shop to access complex technologies designed for scientists building data applications or performing data analytics to extract insights. It automates the creation and manages the operation of computing resources, eliminating the need for enterprises to set up and maintain a high-end R&D cloud infrastructure.

Company information is based on publicly available sources and is reviewed periodically. If you represent this company and would like to request a correction, contact Brel.

Explore Related Intelligence

The AI Brief

Weekly company intelligence in your inbox.

Subscribe